🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

RecruitingNAAges 18 Years - 24 YearsFemaleEUthyroid
NCT06769009 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In EUthyroid2 intervention measures are to be developed, implemented in ambulatory care settings and evaluated to effectively raise awareness for the risks of iodine deficiency among young women (18-24 years) in three European countries (Norway, Poland, UK) as well as Bangladesh and Pakistan. A cluster-randomized controlled trial with three points of measurements will be applied in each participating country. The intervention will be adapted to the different contextual characteristics of the implementation sites. A process evaluation with a convergent parallel mixed methods design will be conducted. For this, participants and healthcare professionals will be surveyed and semi-structured interviews will be carried out.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * non-pregnant Female * Age 18-24 years at the time point of recruitment * Attending the specified settings * Sufficient language skills to understand the study information, informed consent and the questionnaire Exclusion Criteria: * Having a thyroid disease * Pregnancy at the timepoint of recruitment and during the intervention period * Lactation
💊

What it tests

  • Educational intervention measures on iodine, iodine deficiency and iodine intake
📍

Where

6 sites
Bangladesh University of Health
Dhaka, Bangladesh
Institute of Marine Research
Bergen, Norway
Islamia College Peshawar
Peshawar, Pakistan
Jagiellonian University
Krakow, Poland
The Queen's University of Belfast
Belfast, United Kingdom
University of Surrey
Guildford, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy